logo Click here for the Chao Family Comprehensive Cancer Center Home Page Click here for the UC Irvine Home Page

Research Overview

The Chao Family Comprehensive Cancer Center (CFCCC), through its Research Programs and Shared Resources, will continue to leverage its outstanding strengths in structural and chemical biology, optical biology and imaging, biotechnology, bioengineering and nanomedicine, systems biology, and cancer cell biology to make fundamental discoveries about the pathogenesis of cancer, to develop novel molecules and devices for diagnosis and treatment of cancer, and to advance new interventions to prevent cancer, improve cancer outcomes, and enable survivors of cancer to live quality, cancer-free lives.

These efforts are facilitated by CFCCC multidisciplinary Disease-Oriented Teams in Colorectal Cancer, Skin Cancer, Genitourinary Oncology, Gynecologic Oncology, Hematologic Malignancies, and Neurologic Oncology, who provide the necessary expertise in patient-centered and clinical research to bridge the challenging gap between discovery and patient. Translation through the pipeline is further enabled by the CFCCC Stern Center for Cancer Clinical Trials & Research and the collective expertise of CFCCC members in phase I and investigator-initiated clinical trials. Concomitant with this research effort, our multidisciplinary cancer teams will continue to provide state-of-the-art care for patients in our catchment area with relapsed, refractory, complex, and uncommon cancers, and to serve as a referral center for our region’s community hospitals, hematology/oncology practices, and affiliated primary care providers.

Our Aims encompass two other important goals: our commitment to train the next generation of cancer researchers and care providers, and our responsibility to extend the reach of the CFCCC beyond our walls to our catchment area, which includes large multiethnic populations of Asian, Hispanic and Caucasian descent. We leverage our Cancer Center’s regional and national expertise and our National Cancer Institute (NCI) designation, UC Irvine’s National Center for Advancing Translational Sciences (NCATS)-funded Institute for Clinical & Translational Science, and our University of California sister campuses to impact the population of our region and state through public education, policy and practice initiatives at the state and national levels, and community-based research and interventions, in part through our NCI P20-funded partnership with California State University, Fullerton.
Congruent with our overall mission, the Chao Family Comprehensive Cancer Center works at the basic, translational, clinical, educational, community, and health policy levels to help lift the cancer burden from our densely populated and ethnically diverse neighborhoods.